nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—saliva—hepatitis B	0.0225	0.232	CbGeAlD
Mesalazine—MPO—blood plasma—hepatitis B	0.00981	0.101	CbGeAlD
Mesalazine—PPARG—blood plasma—hepatitis B	0.00871	0.0898	CbGeAlD
Mesalazine—Olsalazine—IFNG—hepatitis B	0.00797	0.794	CrCbGaD
Mesalazine—CHUK—blood—hepatitis B	0.00754	0.0777	CbGeAlD
Mesalazine—CHUK—liver—hepatitis B	0.0059	0.0608	CbGeAlD
Mesalazine—IKBKB—blood—hepatitis B	0.00513	0.0528	CbGeAlD
Mesalazine—PTGS1—blood plasma—hepatitis B	0.00465	0.048	CbGeAlD
Mesalazine—PTGS2—blood plasma—hepatitis B	0.00445	0.0459	CbGeAlD
Mesalazine—ALOX5—blood—hepatitis B	0.00425	0.0438	CbGeAlD
Mesalazine—IKBKB—liver—hepatitis B	0.00401	0.0413	CbGeAlD
Mesalazine—MPO—blood—hepatitis B	0.00359	0.0371	CbGeAlD
Mesalazine—ALOX5—liver—hepatitis B	0.00332	0.0342	CbGeAlD
Mesalazine—PPARG—blood—hepatitis B	0.00319	0.0329	CbGeAlD
Mesalazine—MPO—liver—hepatitis B	0.00281	0.029	CbGeAlD
Mesalazine—Abdominal pain upper—Entecavir—hepatitis B	0.0028	0.00564	CcSEcCtD
Mesalazine—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00277	0.00557	CcSEcCtD
Mesalazine—Throat sore—Lamivudine—hepatitis B	0.00272	0.00547	CcSEcCtD
Mesalazine—Oropharyngeal discomfort—Lamivudine—hepatitis B	0.00269	0.00542	CcSEcCtD
Mesalazine—Renal impairment—Telbivudine—hepatitis B	0.00265	0.00533	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.00264	0.00532	CcSEcCtD
Mesalazine—Pancreatitis—Entecavir—hepatitis B	0.0026	0.00524	CcSEcCtD
Mesalazine—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00254	0.00511	CcSEcCtD
Mesalazine—Amblyopia—Lamivudine—hepatitis B	0.00254	0.0051	CcSEcCtD
Mesalazine—Hyperaesthesia—Lamivudine—hepatitis B	0.0025	0.00502	CcSEcCtD
Mesalazine—PPARG—liver—hepatitis B	0.00249	0.0257	CbGeAlD
Mesalazine—Migraine—Telbivudine—hepatitis B	0.00248	0.005	CcSEcCtD
Mesalazine—Neutropenia—Entecavir—hepatitis B	0.00248	0.00499	CcSEcCtD
Mesalazine—Upper respiratory tract infection—Entecavir—hepatitis B	0.00247	0.00496	CcSEcCtD
Mesalazine—Rhinorrhoea—Lamivudine—hepatitis B	0.00242	0.00487	CcSEcCtD
Mesalazine—Blood disorder—Lamivudine—hepatitis B	0.00234	0.00472	CcSEcCtD
Mesalazine—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00234	0.00472	CcSEcCtD
Mesalazine—Acne—Lamivudine—hepatitis B	0.00233	0.00468	CcSEcCtD
Mesalazine—Renal failure—Entecavir—hepatitis B	0.00233	0.00468	CcSEcCtD
Mesalazine—Abdominal pain upper—Telbivudine—hepatitis B	0.0023	0.00464	CcSEcCtD
Mesalazine—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00227	0.00457	CcSEcCtD
Mesalazine—Cramp muscle—Telbivudine—hepatitis B	0.00227	0.00457	CcSEcCtD
Mesalazine—Renal failure—Adefovir Dipivoxil—hepatitis B	0.00227	0.00457	CcSEcCtD
Mesalazine—Haematuria—Entecavir—hepatitis B	0.00226	0.00454	CcSEcCtD
Mesalazine—Nasopharyngitis—Telbivudine—hepatitis B	0.00226	0.00454	CcSEcCtD
Mesalazine—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00225	0.00453	CcSEcCtD
Mesalazine—Hepatobiliary disease—Entecavir—hepatitis B	0.00224	0.0045	CcSEcCtD
Mesalazine—Gastritis—Telbivudine—hepatitis B	0.00223	0.00449	CcSEcCtD
Mesalazine—Vasodilation procedure—Lamivudine—hepatitis B	0.00223	0.00449	CcSEcCtD
Mesalazine—Vasodilation—Lamivudine—hepatitis B	0.00223	0.00449	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00222	0.00448	CcSEcCtD
Mesalazine—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0022	0.00443	CcSEcCtD
Mesalazine—Abdominal distension—Telbivudine—hepatitis B	0.00219	0.00442	CcSEcCtD
Mesalazine—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.00218	0.00439	CcSEcCtD
Mesalazine—Influenza—Telbivudine—hepatitis B	0.00218	0.00439	CcSEcCtD
Mesalazine—Bone disorder—Lamivudine—hepatitis B	0.00217	0.00436	CcSEcCtD
Mesalazine—Rectal haemorrhage—Lamivudine—hepatitis B	0.00217	0.00436	CcSEcCtD
Mesalazine—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.00217	0.00436	CcSEcCtD
Mesalazine—Oropharyngeal pain—Lamivudine—hepatitis B	0.00215	0.00433	CcSEcCtD
Mesalazine—Hepatitis—Entecavir—hepatitis B	0.00212	0.00428	CcSEcCtD
Mesalazine—Oedema peripheral—Entecavir—hepatitis B	0.00209	0.00421	CcSEcCtD
Mesalazine—Abdominal discomfort—Telbivudine—hepatitis B	0.00209	0.00421	CcSEcCtD
Mesalazine—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00207	0.00417	CcSEcCtD
Mesalazine—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00206	0.00414	CcSEcCtD
Mesalazine—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00205	0.00412	CcSEcCtD
Mesalazine—Neutropenia—Telbivudine—hepatitis B	0.00204	0.0041	CcSEcCtD
Mesalazine—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.00204	0.0041	CcSEcCtD
Mesalazine—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00203	0.00409	CcSEcCtD
Mesalazine—Upper respiratory tract infection—Telbivudine—hepatitis B	0.00203	0.00408	CcSEcCtD
Mesalazine—Musculoskeletal pain—Lamivudine—hepatitis B	0.00198	0.00399	CcSEcCtD
Mesalazine—Eructation—Lamivudine—hepatitis B	0.00192	0.00387	CcSEcCtD
Mesalazine—Immune system disorder—Entecavir—hepatitis B	0.00192	0.00386	CcSEcCtD
Mesalazine—Renal failure—Telbivudine—hepatitis B	0.00191	0.00385	CcSEcCtD
Mesalazine—Neuropathy peripheral—Telbivudine—hepatitis B	0.00191	0.00384	CcSEcCtD
Mesalazine—Alopecia—Entecavir—hepatitis B	0.00188	0.00378	CcSEcCtD
Mesalazine—Mental disorder—Entecavir—hepatitis B	0.00186	0.00375	CcSEcCtD
Mesalazine—Aplastic anaemia—Lamivudine—hepatitis B	0.00184	0.0037	CcSEcCtD
Mesalazine—Neuropathy—Lamivudine—hepatitis B	0.00184	0.0037	CcSEcCtD
Mesalazine—Hepatobiliary disease—Telbivudine—hepatitis B	0.00184	0.0037	CcSEcCtD
Mesalazine—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00178	0.00358	CcSEcCtD
Mesalazine—Mouth ulceration—Lamivudine—hepatitis B	0.00177	0.00356	CcSEcCtD
Mesalazine—Back pain—Adefovir Dipivoxil—hepatitis B	0.00175	0.00351	CcSEcCtD
Mesalazine—Hepatitis—Telbivudine—hepatitis B	0.00175	0.00351	CcSEcCtD
Mesalazine—Pharyngitis—Telbivudine—hepatitis B	0.00173	0.00349	CcSEcCtD
Mesalazine—Connective tissue disorder—Telbivudine—hepatitis B	0.00171	0.00345	CcSEcCtD
Mesalazine—PTGS1—blood—hepatitis B	0.00171	0.0176	CbGeAlD
Mesalazine—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00167	0.00336	CcSEcCtD
Mesalazine—Lymphadenopathy—Lamivudine—hepatitis B	0.00167	0.00335	CcSEcCtD
Mesalazine—Leukopenia—Entecavir—hepatitis B	0.00166	0.00333	CcSEcCtD
Mesalazine—PTGS2—blood—hepatitis B	0.00163	0.0168	CbGeAlD
Mesalazine—Gastroenteritis—Lamivudine—hepatitis B	0.0016	0.00323	CcSEcCtD
Mesalazine—Deafness—Lamivudine—hepatitis B	0.00159	0.0032	CcSEcCtD
Mesalazine—Cough—Adefovir Dipivoxil—hepatitis B	0.00157	0.00317	CcSEcCtD
Mesalazine—Mediastinal disorder—Telbivudine—hepatitis B	0.00157	0.00317	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00156	0.00315	CcSEcCtD
Mesalazine—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00154	0.00309	CcSEcCtD
Mesalazine—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00154	0.00309	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00153	0.00307	CcSEcCtD
Mesalazine—Anaphylactic shock—Entecavir—hepatitis B	0.00151	0.00304	CcSEcCtD
Mesalazine—Infection—Entecavir—hepatitis B	0.0015	0.00302	CcSEcCtD
Mesalazine—Renal impairment—Lamivudine—hepatitis B	0.00149	0.00301	CcSEcCtD
Mesalazine—Thirst—Lamivudine—hepatitis B	0.00149	0.00301	CcSEcCtD
Mesalazine—Dysgeusia—Telbivudine—hepatitis B	0.00149	0.00299	CcSEcCtD
Mesalazine—Nervous system disorder—Entecavir—hepatitis B	0.00148	0.00298	CcSEcCtD
Mesalazine—Back pain—Telbivudine—hepatitis B	0.00147	0.00296	CcSEcCtD
Mesalazine—Skin disorder—Entecavir—hepatitis B	0.00147	0.00295	CcSEcCtD
Mesalazine—Muscle spasms—Telbivudine—hepatitis B	0.00146	0.00294	CcSEcCtD
Mesalazine—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00144	0.00291	CcSEcCtD
Mesalazine—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00144	0.0029	CcSEcCtD
Mesalazine—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00143	0.00288	CcSEcCtD
Mesalazine—Ill-defined disorder—Telbivudine—hepatitis B	0.00141	0.00284	CcSEcCtD
Mesalazine—Anorexia—Adefovir Dipivoxil—hepatitis B	0.0014	0.00283	CcSEcCtD
Mesalazine—Migraine—Lamivudine—hepatitis B	0.0014	0.00282	CcSEcCtD
Mesalazine—Affect lability—Lamivudine—hepatitis B	0.0014	0.00282	CcSEcCtD
Mesalazine—Malaise—Telbivudine—hepatitis B	0.00137	0.00276	CcSEcCtD
Mesalazine—Insomnia—Entecavir—hepatitis B	0.00137	0.00275	CcSEcCtD
Mesalazine—Mood swings—Lamivudine—hepatitis B	0.00135	0.00271	CcSEcCtD
Mesalazine—Somnolence—Entecavir—hepatitis B	0.00134	0.0027	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00134	0.0027	CcSEcCtD
Mesalazine—Dyspepsia—Entecavir—hepatitis B	0.00133	0.00267	CcSEcCtD
Mesalazine—Diflunisal—ALB—hepatitis B	0.00133	0.132	CrCbGaD
Mesalazine—Cough—Telbivudine—hepatitis B	0.00133	0.00267	CcSEcCtD
Mesalazine—Liver function test abnormal—Lamivudine—hepatitis B	0.00131	0.00264	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Entecavir—hepatitis B	0.0013	0.00262	CcSEcCtD
Mesalazine—Fatigue—Entecavir—hepatitis B	0.0013	0.00262	CcSEcCtD
Mesalazine—Abdominal pain upper—Lamivudine—hepatitis B	0.0013	0.00261	CcSEcCtD
Mesalazine—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.0013	0.00261	CcSEcCtD
Mesalazine—Arthralgia—Telbivudine—hepatitis B	0.00129	0.0026	CcSEcCtD
Mesalazine—Chest pain—Telbivudine—hepatitis B	0.00129	0.0026	CcSEcCtD
Mesalazine—Myalgia—Telbivudine—hepatitis B	0.00129	0.0026	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00128	0.00259	CcSEcCtD
Mesalazine—Cramp muscle—Lamivudine—hepatitis B	0.00128	0.00258	CcSEcCtD
Mesalazine—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00128	0.00258	CcSEcCtD
Mesalazine—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00128	0.00258	CcSEcCtD
Mesalazine—Discomfort—Telbivudine—hepatitis B	0.00128	0.00257	CcSEcCtD
Mesalazine—PTGS2—liver—hepatitis B	0.00127	0.0131	CbGeAlD
Mesalazine—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00127	0.00256	CcSEcCtD
Mesalazine—Nasopharyngitis—Lamivudine—hepatitis B	0.00127	0.00256	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00125	0.00252	CcSEcCtD
Mesalazine—Abdominal distension—Lamivudine—hepatitis B	0.00124	0.00249	CcSEcCtD
Mesalazine—Gastrointestinal pain—Entecavir—hepatitis B	0.00123	0.00248	CcSEcCtD
Mesalazine—Influenza—Lamivudine—hepatitis B	0.00123	0.00247	CcSEcCtD
Mesalazine—Dysphagia—Lamivudine—hepatitis B	0.00123	0.00247	CcSEcCtD
Mesalazine—Nervous system disorder—Telbivudine—hepatitis B	0.00122	0.00245	CcSEcCtD
Mesalazine—Thrombocytopenia—Telbivudine—hepatitis B	0.00121	0.00244	CcSEcCtD
Mesalazine—Pancreatitis—Lamivudine—hepatitis B	0.0012	0.00242	CcSEcCtD
Mesalazine—Skin disorder—Telbivudine—hepatitis B	0.0012	0.00242	CcSEcCtD
Mesalazine—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.0012	0.00242	CcSEcCtD
Mesalazine—Abdominal pain—Entecavir—hepatitis B	0.00119	0.0024	CcSEcCtD
Mesalazine—Body temperature increased—Entecavir—hepatitis B	0.00119	0.0024	CcSEcCtD
Mesalazine—Bronchitis—Lamivudine—hepatitis B	0.00118	0.00238	CcSEcCtD
Mesalazine—Abdominal discomfort—Lamivudine—hepatitis B	0.00118	0.00237	CcSEcCtD
Mesalazine—Pancytopenia—Lamivudine—hepatitis B	0.00117	0.00235	CcSEcCtD
Mesalazine—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00116	0.00234	CcSEcCtD
Mesalazine—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00116	0.00234	CcSEcCtD
Mesalazine—Dysuria—Lamivudine—hepatitis B	0.00115	0.00231	CcSEcCtD
Mesalazine—Neutropenia—Lamivudine—hepatitis B	0.00115	0.00231	CcSEcCtD
Mesalazine—Pollakiuria—Lamivudine—hepatitis B	0.00114	0.00228	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00113	0.00227	CcSEcCtD
Mesalazine—Insomnia—Telbivudine—hepatitis B	0.00112	0.00226	CcSEcCtD
Mesalazine—Paraesthesia—Telbivudine—hepatitis B	0.00111	0.00224	CcSEcCtD
Mesalazine—Depression—Lamivudine—hepatitis B	0.00109	0.0022	CcSEcCtD
Mesalazine—Dyspepsia—Telbivudine—hepatitis B	0.00109	0.0022	CcSEcCtD
Mesalazine—Stevens-Johnson syndrome—Lamivudine—hepatitis B	0.00109	0.00219	CcSEcCtD
Mesalazine—Asthenia—Entecavir—hepatitis B	0.00108	0.00218	CcSEcCtD
Mesalazine—Renal failure—Lamivudine—hepatitis B	0.00108	0.00217	CcSEcCtD
Mesalazine—Neuropathy peripheral—Lamivudine—hepatitis B	0.00107	0.00216	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00107	0.00215	CcSEcCtD
Mesalazine—Fatigue—Telbivudine—hepatitis B	0.00107	0.00215	CcSEcCtD
Mesalazine—Jaundice—Lamivudine—hepatitis B	0.00107	0.00215	CcSEcCtD
Mesalazine—Stomatitis—Lamivudine—hepatitis B	0.00107	0.00215	CcSEcCtD
Mesalazine—Pain—Telbivudine—hepatitis B	0.00106	0.00213	CcSEcCtD
Mesalazine—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00106	0.00213	CcSEcCtD
Mesalazine—Sweating—Lamivudine—hepatitis B	0.00105	0.00211	CcSEcCtD
Mesalazine—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00104	0.0021	CcSEcCtD
Mesalazine—Hepatobiliary disease—Lamivudine—hepatitis B	0.00104	0.00209	CcSEcCtD
Mesalazine—Epistaxis—Lamivudine—hepatitis B	0.00103	0.00208	CcSEcCtD
Mesalazine—Diarrhoea—Entecavir—hepatitis B	0.00103	0.00208	CcSEcCtD
Mesalazine—Sinusitis—Lamivudine—hepatitis B	0.00103	0.00207	CcSEcCtD
Mesalazine—Agranulocytosis—Lamivudine—hepatitis B	0.00102	0.00206	CcSEcCtD
Mesalazine—Feeling abnormal—Telbivudine—hepatitis B	0.00102	0.00206	CcSEcCtD
Mesalazine—Gastrointestinal pain—Telbivudine—hepatitis B	0.00101	0.00204	CcSEcCtD
Mesalazine—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00101	0.00203	CcSEcCtD
Mesalazine—Dizziness—Entecavir—hepatitis B	0.000998	0.00201	CcSEcCtD
Mesalazine—Rhinitis—Lamivudine—hepatitis B	0.000986	0.00198	CcSEcCtD
Mesalazine—Hepatitis—Lamivudine—hepatitis B	0.000983	0.00198	CcSEcCtD
Mesalazine—Abdominal pain—Telbivudine—hepatitis B	0.00098	0.00197	CcSEcCtD
Mesalazine—Body temperature increased—Telbivudine—hepatitis B	0.00098	0.00197	CcSEcCtD
Mesalazine—Pharyngitis—Lamivudine—hepatitis B	0.000976	0.00196	CcSEcCtD
Mesalazine—Connective tissue disorder—Lamivudine—hepatitis B	0.000966	0.00195	CcSEcCtD
Mesalazine—Vomiting—Entecavir—hepatitis B	0.00096	0.00193	CcSEcCtD
Mesalazine—Rash—Entecavir—hepatitis B	0.000952	0.00192	CcSEcCtD
Mesalazine—Dermatitis—Entecavir—hepatitis B	0.000951	0.00191	CcSEcCtD
Mesalazine—Headache—Entecavir—hepatitis B	0.000945	0.0019	CcSEcCtD
Mesalazine—Vomiting—Adefovir Dipivoxil—hepatitis B	0.000936	0.00188	CcSEcCtD
Mesalazine—Erythema multiforme—Lamivudine—hepatitis B	0.00093	0.00187	CcSEcCtD
Mesalazine—Rash—Adefovir Dipivoxil—hepatitis B	0.000928	0.00187	CcSEcCtD
Mesalazine—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.000928	0.00187	CcSEcCtD
Mesalazine—Headache—Adefovir Dipivoxil—hepatitis B	0.000922	0.00186	CcSEcCtD
Mesalazine—Nausea—Entecavir—hepatitis B	0.000896	0.0018	CcSEcCtD
Mesalazine—Asthenia—Telbivudine—hepatitis B	0.00089	0.00179	CcSEcCtD
Mesalazine—Immune system disorder—Lamivudine—hepatitis B	0.000888	0.00179	CcSEcCtD
Mesalazine—Mediastinal disorder—Lamivudine—hepatitis B	0.000886	0.00178	CcSEcCtD
Mesalazine—Chills—Lamivudine—hepatitis B	0.000882	0.00178	CcSEcCtD
Mesalazine—Pruritus—Telbivudine—hepatitis B	0.000877	0.00177	CcSEcCtD
Mesalazine—Nausea—Adefovir Dipivoxil—hepatitis B	0.000875	0.00176	CcSEcCtD
Mesalazine—Alopecia—Lamivudine—hepatitis B	0.000869	0.00175	CcSEcCtD
Mesalazine—Erythema—Lamivudine—hepatitis B	0.000856	0.00172	CcSEcCtD
Mesalazine—Diarrhoea—Telbivudine—hepatitis B	0.000848	0.00171	CcSEcCtD
Mesalazine—Flatulence—Lamivudine—hepatitis B	0.000844	0.0017	CcSEcCtD
Mesalazine—Tension—Lamivudine—hepatitis B	0.00084	0.00169	CcSEcCtD
Mesalazine—Dysgeusia—Lamivudine—hepatitis B	0.000838	0.00169	CcSEcCtD
Mesalazine—Nervousness—Lamivudine—hepatitis B	0.000832	0.00167	CcSEcCtD
Mesalazine—Back pain—Lamivudine—hepatitis B	0.000828	0.00167	CcSEcCtD
Mesalazine—Muscle spasms—Lamivudine—hepatitis B	0.000823	0.00166	CcSEcCtD
Mesalazine—Dizziness—Telbivudine—hepatitis B	0.00082	0.00165	CcSEcCtD
Mesalazine—Tremor—Lamivudine—hepatitis B	0.000802	0.00161	CcSEcCtD
Mesalazine—Ill-defined disorder—Lamivudine—hepatitis B	0.000794	0.0016	CcSEcCtD
Mesalazine—Anaemia—Lamivudine—hepatitis B	0.000791	0.00159	CcSEcCtD
Mesalazine—Vomiting—Telbivudine—hepatitis B	0.000788	0.00159	CcSEcCtD
Mesalazine—Angioedema—Lamivudine—hepatitis B	0.000782	0.00157	CcSEcCtD
Mesalazine—Rash—Telbivudine—hepatitis B	0.000782	0.00157	CcSEcCtD
Mesalazine—Dermatitis—Telbivudine—hepatitis B	0.000781	0.00157	CcSEcCtD
Mesalazine—Headache—Telbivudine—hepatitis B	0.000777	0.00156	CcSEcCtD
Mesalazine—Malaise—Lamivudine—hepatitis B	0.000772	0.00155	CcSEcCtD
Mesalazine—Vertigo—Lamivudine—hepatitis B	0.000769	0.00155	CcSEcCtD
Mesalazine—Syncope—Lamivudine—hepatitis B	0.000768	0.00155	CcSEcCtD
Mesalazine—Leukopenia—Lamivudine—hepatitis B	0.000766	0.00154	CcSEcCtD
Mesalazine—Loss of consciousness—Lamivudine—hepatitis B	0.000752	0.00151	CcSEcCtD
Mesalazine—Cough—Lamivudine—hepatitis B	0.000747	0.0015	CcSEcCtD
Mesalazine—Salicylic acid—ALB—hepatitis B	0.000739	0.0736	CrCbGaD
Mesalazine—Nausea—Telbivudine—hepatitis B	0.000736	0.00148	CcSEcCtD
Mesalazine—Myalgia—Lamivudine—hepatitis B	0.000729	0.00147	CcSEcCtD
Mesalazine—Arthralgia—Lamivudine—hepatitis B	0.000729	0.00147	CcSEcCtD
Mesalazine—Chest pain—Lamivudine—hepatitis B	0.000729	0.00147	CcSEcCtD
Mesalazine—Anxiety—Lamivudine—hepatitis B	0.000726	0.00146	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.000724	0.00146	CcSEcCtD
Mesalazine—Discomfort—Lamivudine—hepatitis B	0.00072	0.00145	CcSEcCtD
Mesalazine—Dry mouth—Lamivudine—hepatitis B	0.000713	0.00143	CcSEcCtD
Mesalazine—Confusional state—Lamivudine—hepatitis B	0.000705	0.00142	CcSEcCtD
Mesalazine—Anaphylactic shock—Lamivudine—hepatitis B	0.000699	0.00141	CcSEcCtD
Mesalazine—Oedema—Lamivudine—hepatitis B	0.000699	0.00141	CcSEcCtD
Mesalazine—Infection—Lamivudine—hepatitis B	0.000694	0.0014	CcSEcCtD
Mesalazine—Shock—Lamivudine—hepatitis B	0.000687	0.00138	CcSEcCtD
Mesalazine—Nervous system disorder—Lamivudine—hepatitis B	0.000685	0.00138	CcSEcCtD
Mesalazine—Thrombocytopenia—Lamivudine—hepatitis B	0.000684	0.00138	CcSEcCtD
Mesalazine—Skin disorder—Lamivudine—hepatitis B	0.000679	0.00137	CcSEcCtD
Mesalazine—Hyperhidrosis—Lamivudine—hepatitis B	0.000675	0.00136	CcSEcCtD
Mesalazine—Anorexia—Lamivudine—hepatitis B	0.000666	0.00134	CcSEcCtD
Mesalazine—Hypotension—Lamivudine—hepatitis B	0.000653	0.00131	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.000637	0.00128	CcSEcCtD
Mesalazine—Insomnia—Lamivudine—hepatitis B	0.000632	0.00127	CcSEcCtD
Mesalazine—Paraesthesia—Lamivudine—hepatitis B	0.000627	0.00126	CcSEcCtD
Mesalazine—Dyspnoea—Lamivudine—hepatitis B	0.000623	0.00125	CcSEcCtD
Mesalazine—Somnolence—Lamivudine—hepatitis B	0.000621	0.00125	CcSEcCtD
Mesalazine—Dyspepsia—Lamivudine—hepatitis B	0.000615	0.00124	CcSEcCtD
Mesalazine—Decreased appetite—Lamivudine—hepatitis B	0.000607	0.00122	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Lamivudine—hepatitis B	0.000603	0.00121	CcSEcCtD
Mesalazine—Fatigue—Lamivudine—hepatitis B	0.000602	0.00121	CcSEcCtD
Mesalazine—Pain—Lamivudine—hepatitis B	0.000598	0.0012	CcSEcCtD
Mesalazine—Constipation—Lamivudine—hepatitis B	0.000598	0.0012	CcSEcCtD
Mesalazine—Feeling abnormal—Lamivudine—hepatitis B	0.000576	0.00116	CcSEcCtD
Mesalazine—Gastrointestinal pain—Lamivudine—hepatitis B	0.000571	0.00115	CcSEcCtD
Mesalazine—Urticaria—Lamivudine—hepatitis B	0.000555	0.00112	CcSEcCtD
Mesalazine—Body temperature increased—Lamivudine—hepatitis B	0.000552	0.00111	CcSEcCtD
Mesalazine—Abdominal pain—Lamivudine—hepatitis B	0.000552	0.00111	CcSEcCtD
Mesalazine—Hypersensitivity—Lamivudine—hepatitis B	0.000515	0.00104	CcSEcCtD
Mesalazine—Asthenia—Lamivudine—hepatitis B	0.000501	0.00101	CcSEcCtD
Mesalazine—Pruritus—Lamivudine—hepatitis B	0.000494	0.000995	CcSEcCtD
Mesalazine—Diarrhoea—Lamivudine—hepatitis B	0.000478	0.000962	CcSEcCtD
Mesalazine—Dizziness—Lamivudine—hepatitis B	0.000462	0.00093	CcSEcCtD
Mesalazine—Vomiting—Lamivudine—hepatitis B	0.000444	0.000894	CcSEcCtD
Mesalazine—Rash—Lamivudine—hepatitis B	0.000441	0.000887	CcSEcCtD
Mesalazine—Dermatitis—Lamivudine—hepatitis B	0.00044	0.000886	CcSEcCtD
Mesalazine—Headache—Lamivudine—hepatitis B	0.000438	0.000881	CcSEcCtD
Mesalazine—Nausea—Lamivudine—hepatitis B	0.000415	0.000835	CcSEcCtD
Mesalazine—IKBKB—Innate Immune System—IFNB1—hepatitis B	0.000172	0.000434	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—CDKN1A—hepatitis B	0.000172	0.000433	CbGpPWpGaD
Mesalazine—CHUK—Signaling by Interleukins—IL6—hepatitis B	0.000172	0.000433	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—PTEN—hepatitis B	0.000171	0.000432	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—NFKB1—hepatitis B	0.00017	0.00043	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—CDKN1A—hepatitis B	0.000168	0.000425	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—PTEN—hepatitis B	0.000168	0.000424	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IFNA1—hepatitis B	0.000168	0.000423	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—NFKB1—hepatitis B	0.000167	0.000422	CbGpPWpGaD
Mesalazine—IKBKB—MyD88-independent cascade—IL6—hepatitis B	0.000167	0.000421	CbGpPWpGaD
Mesalazine—CHUK—Activated TLR4 signalling—IL6—hepatitis B	0.000166	0.000418	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.000164	0.000415	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000164	0.000414	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.000164	0.000414	CbGpPWpGaD
Mesalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL6—hepatitis B	0.000163	0.000411	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RIT2—hepatitis B	0.000163	0.000411	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SAG—hepatitis B	0.000163	0.000411	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL2—hepatitis B	0.000161	0.000407	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GOT2—hepatitis B	0.000159	0.000402	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—MX1—hepatitis B	0.000158	0.000399	CbGpPWpGaD
Mesalazine—PPARG—Adipogenesis—IL6—hepatitis B	0.000158	0.000398	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—hepatitis B	0.000158	0.000398	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD14—hepatitis B	0.000156	0.000394	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IFNA2—hepatitis B	0.000156	0.000394	CbGpPWpGaD
Mesalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.000156	0.000393	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—CDKN1A—hepatitis B	0.000156	0.000393	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by Interleukins—IL6—hepatitis B	0.000156	0.000393	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—PTEN—hepatitis B	0.000155	0.000392	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—NFKB1—hepatitis B	0.000155	0.00039	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IFNG—hepatitis B	0.000153	0.000387	CbGpPWpGaD
Mesalazine—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.000151	0.000381	CbGpPWpGaD
Mesalazine—IKBKB—Activated TLR4 signalling—IL6—hepatitis B	0.00015	0.000379	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—HNF4A—hepatitis B	0.000149	0.000376	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	0.000148	0.000375	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SAG—hepatitis B	0.000148	0.000372	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RIT2—hepatitis B	0.000148	0.000372	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TGFB1—hepatitis B	0.000145	0.000366	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000144	0.000364	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000143	0.000362	CbGpPWpGaD
Mesalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.000141	0.000356	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD40LG—hepatitis B	0.00014	0.000355	CbGpPWpGaD
Mesalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	0.00014	0.000354	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IFNG—hepatitis B	0.000139	0.000351	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD8A—hepatitis B	0.000139	0.000351	CbGpPWpGaD
Mesalazine—CHUK—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000139	0.00035	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—IL6—hepatitis B	0.000139	0.00035	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SAG—hepatitis B	0.000138	0.000347	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APOBEC3G—hepatitis B	0.000138	0.000347	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GGT1—hepatitis B	0.000137	0.000347	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—GOT1—hepatitis B	0.000137	0.000347	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL2—hepatitis B	0.000136	0.000344	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TNF—hepatitis B	0.000135	0.000342	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000135	0.00034	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000134	0.000338	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—IL6—hepatitis B	0.000133	0.000335	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—AKR1B1—hepatitis B	0.000131	0.000331	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—IL6—hepatitis B	0.000131	0.00033	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—NFKB1—hepatitis B	0.000128	0.000322	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD40LG—hepatitis B	0.000127	0.000322	CbGpPWpGaD
Mesalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	0.000127	0.000321	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—CDKN1A—hepatitis B	0.000126	0.000319	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—PTEN—hepatitis B	0.000126	0.000318	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD8A—hepatitis B	0.000126	0.000318	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GGT2—hepatitis B	0.000126	0.000318	CbGpPWpGaD
Mesalazine—IKBKB—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000126	0.000317	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	0.000126	0.000317	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—NFKB1—hepatitis B	0.000125	0.000317	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000125	0.000316	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—IL6—hepatitis B	0.000125	0.000315	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—IL6—hepatitis B	0.000124	0.000313	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-A—hepatitis B	0.000124	0.000312	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL2—hepatitis B	0.000124	0.000312	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—IL6—hepatitis B	0.000123	0.000312	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—IL6—hepatitis B	0.000123	0.00031	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HSPA5—hepatitis B	0.000122	0.000309	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—hepatitis B	0.000122	0.000307	CbGpPWpGaD
Mesalazine—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	0.00012	0.000302	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—hepatitis B	0.000119	0.000301	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000119	0.0003	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—TLR4—hepatitis B	0.000118	0.000298	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TNF—hepatitis B	0.000117	0.000296	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—NFKB1—hepatitis B	0.000116	0.000292	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—IL6—hepatitis B	0.000116	0.000292	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—IL6—hepatitis B	0.000116	0.000292	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.000116	0.000292	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DPB1—hepatitis B	0.000116	0.000292	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—IL6—hepatitis B	0.000115	0.000289	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—CDKN1A—hepatitis B	0.000115	0.000289	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—PTEN—hepatitis B	0.000114	0.000289	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—NFKB1—hepatitis B	0.000114	0.000287	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—IL6—hepatitis B	0.000114	0.000287	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—HLA-DRB1—hepatitis B	0.000113	0.000285	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—IL6—hepatitis B	0.000113	0.000285	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-A—hepatitis B	0.000112	0.000283	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—IL6—hepatitis B	0.000111	0.000281	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TLR2—hepatitis B	0.000111	0.000281	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HSPA5—hepatitis B	0.000111	0.00028	CbGpPWpGaD
Mesalazine—CHUK—Disease—GOT2—hepatitis B	0.00011	0.000279	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNB1—hepatitis B	0.00011	0.000279	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—CYP2A6—hepatitis B	0.000109	0.000275	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNA1—hepatitis B	0.000108	0.000272	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—TLR4—hepatitis B	0.000107	0.00027	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000106	0.000268	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000106	0.000267	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.000105	0.000265	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DPB1—hepatitis B	0.000105	0.000265	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—AKR1B1—hepatitis B	0.000104	0.000263	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—hepatitis B	0.000103	0.000261	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000103	0.000261	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000103	0.00026	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000103	0.000259	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—HLA-DRB1—hepatitis B	0.000103	0.000259	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000102	0.000259	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000102	0.000256	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TLR2—hepatitis B	0.000101	0.000254	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNA2—hepatitis B	0.0001	0.000253	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD14—hepatitis B	0.0001	0.000253	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNB1—hepatitis B	0.0001	0.000253	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GGT2—hepatitis B	9.99e-05	0.000252	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GOT2—hepatitis B	9.85e-05	0.000249	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNA1—hepatitis B	9.76e-05	0.000246	CbGpPWpGaD
Mesalazine—CHUK—Disease—GOT1—hepatitis B	9.53e-05	0.000241	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL6—hepatitis B	9.47e-05	0.000239	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD14—hepatitis B	9.08e-05	0.000229	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNA2—hepatitis B	9.08e-05	0.000229	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—CTNNB1—hepatitis B	8.9e-05	0.000225	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—NFKB1—hepatitis B	8.63e-05	0.000218	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	8.55e-05	0.000216	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL18—hepatitis B	8.55e-05	0.000216	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD40LG—hepatitis B	8.52e-05	0.000215	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GGT1—hepatitis B	8.5e-05	0.000215	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—GOT1—hepatitis B	8.5e-05	0.000215	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD8A—hepatitis B	8.42e-05	0.000213	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CD4—hepatitis B	8.31e-05	0.00021	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL6—hepatitis B	8.01e-05	0.000202	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	7.98e-05	0.000202	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CD4—hepatitis B	7.98e-05	0.000201	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—IL6—hepatitis B	7.88e-05	0.000199	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL18—hepatitis B	7.75e-05	0.000196	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	7.75e-05	0.000196	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD40LG—hepatitis B	7.72e-05	0.000195	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD8A—hepatitis B	7.64e-05	0.000193	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP2A6—hepatitis B	7.63e-05	0.000193	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CD4—hepatitis B	7.53e-05	0.00019	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-A—hepatitis B	7.51e-05	0.00019	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CTNNB1—hepatitis B	7.38e-05	0.000186	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ALB—hepatitis B	7.3e-05	0.000184	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL6—hepatitis B	7.26e-05	0.000183	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CD4—hepatitis B	7.23e-05	0.000183	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CDKN1A—hepatitis B	7.21e-05	0.000182	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—PTEN—hepatitis B	7.19e-05	0.000182	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TGFB1—hepatitis B	7.19e-05	0.000182	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—NFKB1—hepatitis B	7.16e-05	0.000181	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—IL6—hepatitis B	7.14e-05	0.00018	CbGpPWpGaD
Mesalazine—CHUK—Disease—CCR5—hepatitis B	7.11e-05	0.00018	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	7.11e-05	0.00018	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	7.04e-05	0.000178	CbGpPWpGaD
Mesalazine—CHUK—Disease—HLA-A—hepatitis B	6.93e-05	0.000175	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—CDKN1A—hepatitis B	6.92e-05	0.000175	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—PTEN—hepatitis B	6.9e-05	0.000174	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GOT2—hepatitis B	6.9e-05	0.000174	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—NFKB1—hepatitis B	6.87e-05	0.000173	CbGpPWpGaD
Mesalazine—CHUK—Immune System—TLR4—hepatitis B	6.87e-05	0.000173	CbGpPWpGaD
Mesalazine—CHUK—Immune System—HLA-DRB1—hepatitis B	6.86e-05	0.000173	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-A—hepatitis B	6.81e-05	0.000172	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—TNF—hepatitis B	6.71e-05	0.000169	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CTNNB1—hepatitis B	6.69e-05	0.000169	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GOT2—hepatitis B	6.54e-05	0.000165	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CDKN1A—hepatitis B	6.54e-05	0.000165	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—PTEN—hepatitis B	6.52e-05	0.000165	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—NFKB1—hepatitis B	6.49e-05	0.000164	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CXCL10—hepatitis B	6.42e-05	0.000162	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—CDKN1A—hepatitis B	6.28e-05	0.000158	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—PTEN—hepatitis B	6.26e-05	0.000158	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—NFKB1—hepatitis B	6.23e-05	0.000157	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—TLR4—hepatitis B	6.23e-05	0.000157	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—HLA-DRB1—hepatitis B	6.22e-05	0.000157	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP2A6—hepatitis B	6.05e-05	0.000153	CbGpPWpGaD
Mesalazine—CHUK—Disease—NOS2—hepatitis B	6.03e-05	0.000152	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GOT1—hepatitis B	5.95e-05	0.00015	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—GGT1—hepatitis B	5.95e-05	0.00015	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CXCL10—hepatitis B	5.82e-05	0.000147	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	5.65e-05	0.000143	CbGpPWpGaD
Mesalazine—PTGS2—Disease—GOT1—hepatitis B	5.64e-05	0.000142	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PTEN—hepatitis B	5.57e-05	0.000141	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT2—hepatitis B	5.48e-05	0.000138	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	5.43e-05	0.000137	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—IL6—hepatitis B	5.42e-05	0.000137	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IFNG—hepatitis B	5.01e-05	0.000126	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCR5—hepatitis B	4.98e-05	0.000126	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CD4—hepatitis B	4.84e-05	0.000122	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GOT1—hepatitis B	4.73e-05	0.000119	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—GGT1—hepatitis B	4.73e-05	0.000119	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IFNG—hepatitis B	4.54e-05	0.000115	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ALB—hepatitis B	4.52e-05	0.000114	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCR5—hepatitis B	4.52e-05	0.000114	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IL6—hepatitis B	4.49e-05	0.000113	CbGpPWpGaD
Mesalazine—CHUK—Disease—CD4—hepatitis B	4.47e-05	0.000113	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2—hepatitis B	4.45e-05	0.000112	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CD4—hepatitis B	4.39e-05	0.000111	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	4.31e-05	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTNNB1—hepatitis B	4.3e-05	0.000108	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—F2—hepatitis B	4.27e-05	0.000108	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CCR5—hepatitis B	4.21e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CDKN1A—hepatitis B	4.2e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PTEN—hepatitis B	4.19e-05	0.000106	CbGpPWpGaD
Mesalazine—CHUK—Immune System—NFKB1—hepatitis B	4.17e-05	0.000105	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HLA-A—hepatitis B	4.11e-05	0.000104	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IL6—hepatitis B	4.07e-05	0.000103	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2—hepatitis B	4.04e-05	0.000102	CbGpPWpGaD
Mesalazine—CHUK—Disease—CTNNB1—hepatitis B	3.97e-05	0.0001	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTNNB1—hepatitis B	3.9e-05	9.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—CDKN1A—hepatitis B	3.88e-05	9.78e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—F2—hepatitis B	3.87e-05	9.78e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—PTEN—hepatitis B	3.87e-05	9.76e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CDKN1A—hepatitis B	3.81e-05	9.61e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PTEN—hepatitis B	3.8e-05	9.59e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—NFKB1—hepatitis B	3.78e-05	9.54e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—NOS2—hepatitis B	3.57e-05	9.02e-05	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PTEN—hepatitis B	3.45e-05	8.71e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—TGFB1—hepatitis B	3.21e-05	8.09e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ALB—hepatitis B	3.17e-05	8e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2—hepatitis B	2.88e-05	7.27e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CTNNB1—hepatitis B	2.78e-05	7.01e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CDKN1A—hepatitis B	2.71e-05	6.85e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTEN—hepatitis B	2.71e-05	6.84e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NFKB1—hepatitis B	2.69e-05	6.8e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CD4—hepatitis B	2.65e-05	6.68e-05	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL6—hepatitis B	2.62e-05	6.61e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2—hepatitis B	2.61e-05	6.59e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CTNNB1—hepatitis B	2.52e-05	6.36e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ALB—hepatitis B	2.51e-05	6.35e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CDKN1A—hepatitis B	2.46e-05	6.21e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTEN—hepatitis B	2.46e-05	6.2e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NFKB1—hepatitis B	2.44e-05	6.17e-05	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PTEN—hepatitis B	2.42e-05	6.1e-05	CbGpPWpGaD
Mesalazine—CHUK—Disease—IL6—hepatitis B	2.42e-05	6.1e-05	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL6—hepatitis B	2.37e-05	5.99e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CTNNB1—hepatitis B	2.35e-05	5.93e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CDKN1A—hepatitis B	2.3e-05	5.8e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PTEN—hepatitis B	2.29e-05	5.78e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TGFB1—hepatitis B	2.24e-05	5.67e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TGFB1—hepatitis B	2.04e-05	5.14e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PTEN—hepatitis B	1.92e-05	4.84e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—TGFB1—hepatitis B	1.9e-05	4.79e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—hepatitis B	1.85e-05	4.67e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL6—hepatitis B	1.69e-05	4.27e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—hepatitis B	1.68e-05	4.23e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL6—hepatitis B	1.53e-05	3.87e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IL6—hepatitis B	1.43e-05	3.61e-05	CbGpPWpGaD
